β-adrenoceptor activation impacts galectin-3 as a biomarker and therapeutic target in heart disease. | |
Du Xiao-Jun; Zhao Wei-Bo; Nguyen My-Nhan; Lu Qun; Kiriazis Helen | |
刊名 | British journal of pharmacology |
2019 | |
关键词 | Hippo pathway YAP &beta -adrenoceptor Mst1 galectin-3 heart disease fibrosis |
ISSN号 | 1476-5381 |
URL标识 | 查看原文 |
内容类型 | 期刊论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/2828002 |
专题 | 西安交通大学 |
推荐引用方式 GB/T 7714 | Du Xiao-Jun,Zhao Wei-Bo,Nguyen My-Nhan,et al. β-adrenoceptor activation impacts galectin-3 as a biomarker and therapeutic target in heart disease.[J]. British journal of pharmacology,2019. |
APA | Du Xiao-Jun,Zhao Wei-Bo,Nguyen My-Nhan,Lu Qun,&Kiriazis Helen.(2019).β-adrenoceptor activation impacts galectin-3 as a biomarker and therapeutic target in heart disease..British journal of pharmacology. |
MLA | Du Xiao-Jun,et al."β-adrenoceptor activation impacts galectin-3 as a biomarker and therapeutic target in heart disease.".British journal of pharmacology (2019). |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论